MISSION WEALTH MANAGEMENT, LP
Position in GILD — Gilead Sciences, Inc.
CIK 1645382
Santa Barbara, CA
Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,132,492
+$521,515 QoQ
Shares Held
16,879
+46.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#810
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2020CallValue
$30,776
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MISSION WEALTH MANAGEMENT, LP holds $105,799,986 across 14 Drug Manufacturers - General names. GILD ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,625 | $30,735,396 | |
| 2 | JNJ |
Johnson & Johnson
|
96,816 | $24,588,359 | |
| 3 | ABBV |
AbbVie Inc.
|
69,052 | $17,376,245 | |
| 4 | MRK |
Merck & Co., Inc.
|
72,281 | $9,288,108 | |
| 5 | AMGN |
Amgen Inc
|
25,436 | $9,210,884 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
59,419 | $3,423,722 | |
| 7 | NVS |
Novartis AG
|
19,690 | $3,085,816 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
16,879 | $2,132,492 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,132,492 | 16,879 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,610,977 | 11,559 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,557,447 | 12,689 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,422,354 | 12,814 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,427,783 | 12,878 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,446,565 | 12,910 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $981,431 | 10,625 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,010,607 | 12,054 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $855,360 | 12,467 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $912,255 | 12,454 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $979,086 | 12,086 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $803,281 | 10,719 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $799,909 | 10,379 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,486,573 | 17,917 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $1,538,517 | 17,921 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,283,213 | 20,801 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,216,915 | 19,688 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,303,381 | 21,924 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $989,093 | 13,622 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $998,086 | 14,289 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,124,414 | 16,329 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,088,369 | 16,840 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,103,036 | 18,933 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,131,922 | 17,913 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $30,776 | 400 | Call | Sole | 2020-08-03 | |
| 2020-06-30 | $1,366,839 | 17,765 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,252,603 | 16,755 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||